Closing Bell: Nervgen Pharma Corp down on Thursday (NGEN)

Nervgen Pharma Corp opened trading today at $2.90 and closed at $2.74. Intraday prices ranged from a low of $2.66 to a high of $2.94.

Share prices dipped -3.52 percent from the previous day's close of $2.84.

During the day across North America, the TSX Composite closed 0.02% at 21793.90, the S&P 500 closed 0.16% at 5477.90, the Dow Jones Industrial Average closed 0.04% at 39127.80 and the Nasdaq Composite closed 0.49% at 17805.16.

Nervgen Pharma Corp has listed on the Toronto Venture Exchange (TSX-V) under the ticker NGEN.

Trading volume was 122,695 on 206 total trades, with an average volume of 101,896 over 5 days.

The TSX-V market on the whole today saw 3,034 price advancers against 2,170 declines and 124 unchanged.

During the prior 52 weeks, NGEN.VN has traded as high as $3.98 (February 05,2024) and low as $1.58 (December 14,2023). Moreover, the shares have boosted 60.23 percent in the last 52 weeks, while they have advanced 1.48% this year.

Following today's trading, Nervgen Pharma Corp has a market capitalization of $174.82 million on a float of 69,928 shares outstanding. Its annual EPS is $-0.34.

Nervgen Pharma Corp is a TSX Biotechnology company headquartered in Vancouver, CAN.

Currently, Nervgen Pharma Corp has an average recommendation of "Strong Sell" based on 0.00 analysts according to Zacks. Currently, there are for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..